These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17710892)

  • 1. [Cancer immunotherapy using dendritic cells: current status and perspective].
    Okano S; Yonemitsu Y; Sueishi K
    Fukuoka Igaku Zasshi; 2007 Jul; 98(7):277-86. PubMed ID: 17710892
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cancer immunotherapy].
    Vakkila J; Pihkala U
    Duodecim; 1999; 115(7):785-94. PubMed ID: 11859512
    [No Abstract]   [Full Text] [Related]  

  • 3. The therapeutic role of dendritic cells in cancer immunotherapy.
    Lemoli RM; Curti A; Fogli M; Ferri E; Baccarani M
    Haematologica; 2002 Aug; 87(8 Suppl):62-6. PubMed ID: 12412393
    [No Abstract]   [Full Text] [Related]  

  • 4. Monocyte-derived dendritic cells: a promising armament for immunotherapy in human malignancies.
    Yi Q; Kwak LW
    Clin Cancer Res; 2005 Feb; 11(3):966-7. PubMed ID: 15709160
    [No Abstract]   [Full Text] [Related]  

  • 5. Cancer Immunotherapy by coordinated stimulation of innate lymphocytes (NK and NKT cells).
    Fujii S
    Rinsho Ketsueki; 2009 May; 50(5):364-74. PubMed ID: 19483396
    [No Abstract]   [Full Text] [Related]  

  • 6. Tumor-dendritic cell fusion technology and immunotherapy strategies.
    Shu S; Cohen P
    J Immunother; 2001; 24(2):99-100. PubMed ID: 11265778
    [No Abstract]   [Full Text] [Related]  

  • 7. Dendritic cells in the treatment of cancer.
    Engleman EG
    Biol Blood Marrow Transplant; 1996 Oct; 2(3):115-7. PubMed ID: 9199753
    [No Abstract]   [Full Text] [Related]  

  • 8. Cancer therapy-induced immune modulation.
    Karl JC; Mackall CL
    Cancer Chemother Biol Response Modif; 2005; 22():325-41. PubMed ID: 16110619
    [No Abstract]   [Full Text] [Related]  

  • 9. [Dendritic cells and cancer therapy].
    Baggers J
    Ugeskr Laeger; 2000 Oct; 162(44):5940-1. PubMed ID: 11094562
    [No Abstract]   [Full Text] [Related]  

  • 10. Advances in specific immunotherapy for prostate cancer.
    Kiessling A; Füssel S; Wehner R; Bachmann M; Wirth MP; Rieber EP; Schmitz M
    Eur Urol; 2008 Apr; 53(4):694-708. PubMed ID: 18061335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy with dendritic cells for cancer.
    Ballestrero A; Boy D; Moran E; Cirmena G; Brossart P; Nencioni A
    Adv Drug Deliv Rev; 2008 Jan; 60(2):173-83. PubMed ID: 17977615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell fusion: from hybridoma to dendritic cell-based vaccine.
    Gong J; Koido S; Calderwood SK
    Expert Rev Vaccines; 2008 Sep; 7(7):1055-68. PubMed ID: 18767954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cells in cancer immunotherapy.
    Vulink A; Radford KJ; Melief C; Hart DN
    Adv Cancer Res; 2008; 99():363-407. PubMed ID: 18037410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cell-based cancer immunotherapies.
    Fujii S; Takayama T; Asakura M; Aki K; Fujimoto K; Shimizu K
    Arch Immunol Ther Exp (Warsz); 2009; 57(3):189-98. PubMed ID: 19479202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cell-based tumor immunotherapy.
    Kadowaki N; Kitawaki T
    Rinsho Ketsueki; 2009 May; 50(5):358-63. PubMed ID: 19483395
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of dendritic cells in cancer immunotherapy.
    Nencioni A; Grünebach F; Schmidt SM; Müller MR; Boy D; Patrone F; Ballestrero A; Brossart P
    Crit Rev Oncol Hematol; 2008 Mar; 65(3):191-9. PubMed ID: 18055210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting.
    Tacken PJ; de Vries IJ; Torensma R; Figdor CG
    Nat Rev Immunol; 2007 Oct; 7(10):790-802. PubMed ID: 17853902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential applications for plasmacytoid dendritic cells in cancer immunotherapy.
    Tel J; de Vries IJ
    Immunotherapy; 2012 Oct; 4(10):979-82. PubMed ID: 23148748
    [No Abstract]   [Full Text] [Related]  

  • 19. Immune modulation with dendritic cells.
    Panoskaltsis N; Reid CD; Knight SC
    Transfus Med; 2004 Apr; 14(2):81-96. PubMed ID: 15113373
    [No Abstract]   [Full Text] [Related]  

  • 20. The ongoing evolution of dendritic cell therapy.
    Sokoloff MH; Vogelzang N
    Cancer; 1999 Dec; 86(12):2593-6. PubMed ID: 10594853
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.